
Over the last 7 days, the Clinical Research and Equipment industry has dropped 3.3%, driven by Locus Cell declining 10%. Overall the industry is down 5.5% in 12 months.
Has the Taiwanese Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 15 Jun 2026 | NT$31.6b | NT$2.7b | -NT$747,832,000.00 | 21.6x | -42.2x | 11.9x |
| Wed, 13 May 2026 | NT$34.4b | NT$2.5b | -NT$764,028,000.00 | 21.7x | -45x | 13.6x |
| Fri, 10 Apr 2026 | NT$31.3b | NT$2.5b | -NT$767,980,000.00 | 21.1x | -40.8x | 12.5x |
| Sun, 08 Mar 2026 | NT$32.5b | NT$2.4b | -NT$692,870,000.00 | 19.5x | -46.9x | 13.4x |
| Tue, 03 Feb 2026 | NT$33.2b | NT$2.4b | -NT$689,929,000.00 | 24.1x | -48.2x | 13.7x |
| Thu, 01 Jan 2026 | NT$33.9b | NT$2.4b | -NT$689,929,000.00 | 25.8x | -49.2x | 14x |
| Sat, 29 Nov 2025 | NT$37.9b | NT$2.4b | -NT$670,921,000.00 | 19.9x | -56.5x | 15.5x |
| Mon, 27 Oct 2025 | NT$36.9b | NT$2.5b | -NT$870,437,000.00 | 18.4x | -42.4x | 15x |
| Wed, 24 Sep 2025 | NT$34.5b | NT$2.5b | -NT$870,437,000.00 | 19.8x | -39.6x | 14x |
| Fri, 22 Aug 2025 | NT$34.7b | NT$2.5b | -NT$819,216,000.00 | 20.6x | -42.4x | 14.2x |
| Sun, 20 Jul 2025 | NT$34.4b | NT$2.5b | -NT$600,003,000.00 | 22.3x | -57.4x | 14x |
| Tue, 17 Jun 2025 | NT$33.1b | NT$2.5b | -NT$600,003,000.00 | 23.6x | -55.1x | 13.4x |
| Thu, 15 May 2025 | NT$32.0b | NT$2.5b | -NT$539,009,000.00 | 22.9x | -59.3x | 12.9x |
| Sat, 12 Apr 2025 | NT$30.7b | NT$2.5b | -NT$540,128,000.00 | 23.4x | -56.9x | 12.5x |
| Mon, 10 Mar 2025 | NT$36.1b | NT$2.6b | -NT$854,432,000.00 | 24.2x | -42.3x | 14.1x |
| Wed, 05 Feb 2025 | NT$37.1b | NT$2.6b | -NT$854,432,000.00 | 23.5x | -43.5x | 14.5x |
| Fri, 03 Jan 2025 | NT$34.4b | NT$2.6b | -NT$854,432,000.00 | 22.9x | -40.3x | 13.4x |
| Sun, 01 Dec 2024 | NT$42.2b | NT$2.6b | -NT$854,432,000.00 | 23.7x | -49.4x | 16.5x |
| Tue, 29 Oct 2024 | NT$41.6b | NT$2.5b | -NT$712,402,000.00 | 24.4x | -58.4x | 16.6x |
| Thu, 26 Sep 2024 | NT$42.8b | NT$2.3b | -NT$836,610,000.00 | 22.3x | -51.2x | 18.8x |
| Sat, 24 Aug 2024 | NT$40.9b | NT$2.3b | -NT$836,610,000.00 | 22.3x | -48.9x | 18x |
| Mon, 22 Jul 2024 | NT$43.3b | NT$2.1b | -NT$797,765,000.00 | 33.6x | -54.3x | 20.3x |
| Wed, 19 Jun 2024 | NT$42.1b | NT$2.1b | -NT$797,765,000.00 | 33.9x | -52.8x | 19.7x |
| Fri, 17 May 2024 | NT$40.0b | NT$2.1b | -NT$893,893,000.00 | 32.2x | -44.8x | 18.8x |
| Sun, 14 Apr 2024 | NT$40.9b | NT$2.1b | -NT$903,875,000.00 | 30.9x | -45.3x | 19.4x |
| Tue, 12 Mar 2024 | NT$40.7b | NT$2.1b | -NT$611,249,000.00 | 32.7x | -66.5x | 19.7x |
| Thu, 08 Feb 2024 | NT$43.0b | NT$2.1b | -NT$610,218,000.00 | 32.4x | -70.4x | 20.7x |
| Sat, 06 Jan 2024 | NT$46.5b | NT$2.1b | -NT$610,218,000.00 | 34.4x | -76.3x | 22.4x |
| Mon, 04 Dec 2023 | NT$48.8b | NT$2.1b | -NT$610,218,000.00 | 33.4x | -80x | 23.5x |
| Wed, 01 Nov 2023 | NT$49.8b | NT$2.2b | -NT$497,769,000.00 | 31.1x | -100x | 22.4x |
| Fri, 29 Sep 2023 | NT$48.0b | NT$2.2b | -NT$497,769,000.00 | 31.3x | -96.4x | 21.6x |
| Sun, 27 Aug 2023 | NT$43.1b | NT$2.2b | -NT$497,769,000.00 | 31.3x | -86.5x | 19.4x |
| Tue, 25 Jul 2023 | NT$48.5b | NT$2.5b | -NT$274,767,000.00 | 42.4x | -176.5x | 19.8x |
| Thu, 22 Jun 2023 | NT$48.4b | NT$2.5b | -NT$274,767,000.00 | 43.2x | -176.1x | 19.7x |
-176.1x
How does Taiwanese Clinical Research and Equipment compare with similar industries?
| TW Market | -2.06% | |
| Healthcare | -1.43% | |
| Life Sciences | -3.34% | |
| Clinical Research and Equipment | -3.34% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6589 EirGenix | NT$44.85 | 1.1% +NT$151.3m | -27.8% | PS12x | |
| 6662 BioLASCO Taiwan | NT$30.20 | 2.4% +NT$17.9m | -10.4% | PE18.2x | |
| 6848 RBC Bioscience | NT$20.85 | 6.4% +NT$17.8m | 22.3% | PE12.6x |